Davide Festi

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases
    Davide Festi
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola Malpighi, Bologna, Italy
    Curr Clin Pharmacol 2:155-77. 2007
  2. ncbi Gut microbiota and its pathophysiology in disease paradigms
    Davide Festi
    Department of Clinical Medicine, University of Bologna, S Orsola Malpighi Hospital, Bologna, Italy
    Dig Dis 29:518-24. 2011
  3. ncbi Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project)
    Davide Festi
    Dipartimento di Medicina Interna e Gastroenterologia, Policlinico S Orsola Malpighi, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 14:5282-9. 2008
  4. ncbi Body weight, lifestyle, dietary habits and gastroesophageal reflux disease
    Davide Festi
    Department of Clinical Medicine, S Orsola Malpighi Hospital, Bologna, Italy
    World J Gastroenterol 15:1690-701. 2009
  5. ncbi Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study
    Davide Festi
    Department of Clinical Medicine, University of Bologna, Bologna, Italy
    J Gastroenterol Hepatol 25:719-24. 2010
  6. ncbi Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial
    M Francesca Jaboli
    Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
    World J Gastroenterol 9:1491-5. 2003
  7. ncbi Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis
    Francesco Azzaroli
    Department of Internal Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna
    World J Gastroenterol 10:3099-102. 2004
  8. ncbi Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure
    Antonio Colecchia
    Department of Clinical Medicine, University of Bologna, Italy
    Dig Liver Dis 43:659-63. 2011
  9. ncbi Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, UO di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 12:7239-49. 2006
  10. ncbi Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease
    Antonio Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Cristo Re Hospital, Rome, Italy
    World J Gastroenterol 13:264-9. 2007

Collaborators

Detail Information

Publications26

  1. ncbi Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases
    Davide Festi
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola Malpighi, Bologna, Italy
    Curr Clin Pharmacol 2:155-77. 2007
    ..The future availability of UDCA derivatives will possibly enhance the chances to effectively treat chronic cholestatic diseases...
  2. ncbi Gut microbiota and its pathophysiology in disease paradigms
    Davide Festi
    Department of Clinical Medicine, University of Bologna, S Orsola Malpighi Hospital, Bologna, Italy
    Dig Dis 29:518-24. 2011
    ....
  3. ncbi Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project)
    Davide Festi
    Dipartimento di Medicina Interna e Gastroenterologia, Policlinico S Orsola Malpighi, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 14:5282-9. 2008
    ..To evaluate gallstone incidence and risk factors in a large population-based study...
  4. ncbi Body weight, lifestyle, dietary habits and gastroesophageal reflux disease
    Davide Festi
    Department of Clinical Medicine, S Orsola Malpighi Hospital, Bologna, Italy
    World J Gastroenterol 15:1690-701. 2009
    ..Mild routine physical activity in association with diet modifications, i.e. a diet rich in fiber and low in fat, is advisable in preventing reflux symptoms...
  5. ncbi Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study
    Davide Festi
    Department of Clinical Medicine, University of Bologna, Bologna, Italy
    J Gastroenterol Hepatol 25:719-24. 2010
    ..The knowledge of natural history is essential for disease management. We evaluated the natural history (e.g. frequency and characteristics of symptoms and clinical outcome) of gallstones (GS) in a population-based cohort study...
  6. ncbi Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial
    M Francesca Jaboli
    Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
    World J Gastroenterol 9:1491-5. 2003
    ..Studies with other regimens regarding sequence and duration are needed...
  7. ncbi Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis
    Francesco Azzaroli
    Department of Internal Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna
    World J Gastroenterol 10:3099-102. 2004
    ..Data on the preventive effect of IFN plus ribavirin treatment are lacking...
  8. ncbi Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure
    Antonio Colecchia
    Department of Clinical Medicine, University of Bologna, Italy
    Dig Liver Dis 43:659-63. 2011
    ..After a Kasai procedure, 70% of patients with biliary atresia develop chronic liver disease with portal hypertension and oesophageal varices...
  9. ncbi Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, UO di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 12:7239-49. 2006
    ..Thus the real contribution of medical treatment to HCC prevention in patients with chronic viral hepatitis is small. Great efforts are needed to identify more effective medical measures for primary and secondary prevention of HCC...
  10. ncbi Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease
    Antonio Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Cristo Re Hospital, Rome, Italy
    World J Gastroenterol 13:264-9. 2007
    ..To comparatively evaluate the long term efficacy of Rifaximin and dietary fibers in reducing symptoms and/or complication frequency in symptomatic, uncomplicated diverticular disease...
  11. ncbi Natural history of small gallbladder polyps is benign: evidence from a clinical and pathogenetic study
    Antonio Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
    Am J Gastroenterol 104:624-9. 2009
    ..It is unclear if these polyps and gallstones represent different aspects of the same disease. The aim of this study was to characterize the natural history and pathogenesis of small gallbladder polyps...
  12. ncbi Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment
    Antonio Colecchia
    Department of Clinical Medicine, University of Bologna, Italy
    J Hepatol 54:300-5. 2011
    ..Our aim was to determine the long-term safety and the overall accuracy of NCB in assessing tumour grading in subjects who had undergone liver resection for a single HCC...
  13. ncbi Proton pump inhibitors in cirrhosis: tradition or evidence based practice?
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, U O di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 14:2980-5. 2008
    ..In conclusion, the use of this class of drugs seems more habit related than evidence-based eventually leading to an increase in health costs...
  14. ncbi Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy
    Carlo Fabbri
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    World J Gastroenterol 9:1487-90. 2003
    ....
  15. ncbi Diverticular disease of the colon: new perspectives in symptom development and treatment
    Antonio Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
    World J Gastroenterol 9:1385-9. 2003
    ..These perspectives on symptom development are reviewed and new therapeutic approaches are hypothesized...
  16. ncbi Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting
    Antonio Colecchia
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Am J Gastroenterol 101:2576-81; quiz 2672. 2006
    ....
  17. ncbi The UDCA dosage deficit: a fate shared with CDCA
    Enrico Roda
    Dipartimento di Medicina Interna e Gastroenterologia, , Bologna, Italy
    Eur J Gastroenterol Hepatol 14:213-6. 2002
    ..It may be necessary to re-evaluate the dosage of UDCA that provides the most effective treatment...
  18. ncbi Prevalence of gallstone disease in first-degree relatives of patients with cholelithiasis
    Adolfo Francesco Attili
    GI Unit, Department of Clinical Medicine, Policlinico Umberto I, Rome 00185, Italy
    World J Gastroenterol 11:6508-11. 2005
    ..To evaluate the influence of familiality on the prevalence of gallstone disease (GD) in Italy...
  19. ncbi Management of hepatic encephalopathy: focus on antibiotic therapy
    Davide Festi
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Digestion 73:94-101. 2006
    ..Available evidence suggests that rifaximin - thanks to its efficacy and remarkable safety - has the highest benefit-risk ratio in the overall treatment of HE...
  20. ncbi Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk
    Francesca Maffei
    Department of Pharmacology, University of Bologna, Bologna, Italy
    Mutat Res 714:88-92. 2011
    ..89±3.42) with respect to control (MN: 6.37±0.96 P<0.05). These results can contribute to define plasma biomarkers associated to oxidative stress damage that could predictive of CR cancer risk...
  21. ncbi Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor?
    Riccardo Masetti
    Paediatric Oncology and Haematology Unit Lalla Seràgnoli, University of Bologna Sant Orsola Malpighi Hospital, Bologna, Italy
    Eur J Pediatr 170:807-12. 2011
    ..The aim of this report is to provide useful diagnostic tools to facilitate accurate diagnosis of FNH and suggest a correct management of this benign lesion during postcancer follow-up...
  22. ncbi Treatment of non-alcoholic fatty liver disease with focus on emerging drugs
    Giulio Marchesini
    University of Bologna, Unit of Metabolic Diseases and Clinical Dietetics, 9, Via Massarenti, I 40138 Bologna, Italy
    Expert Opin Emerg Drugs 16:121-36. 2011
    ..Several ongoing studies are testing the effectiveness of new approaches on histological outcomes and new metabolic pathways are under scrutiny...
  23. ncbi Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness
    Veronica Salvatore
    Department of Digestive Disease and Internal Medicine, Azienda Ospedaliero Universitaria di Bologna Policlinico S Orsola Malpighi, Bologna, Italy
    Dig Liver Dis 44:154-9. 2012
    ..We tested the relationship between hepatic haemodynamics assessed by Doppler ultrasonography and liver stiffness assessed by Transient Elastography in hepatitis C related chronic liver disease...
  24. ncbi Antioxidant properties of ursodeoxycholic acid
    Domenico Lapenna
    Dipartimento di Medicina e Scienze dell Invecchiamento, Facolta di Medicina e Chirurgia, Universita G D Annunzio, 66100 Scalo, Chieti, Italy
    Biochem Pharmacol 64:1661-7. 2002
    ..rad;-dependent biomolecular oxidative damage; such properties are evident at therapeutically relevant drug concentrations, suggesting that UDCA could act as an antioxidant in vivo...
  25. ncbi Biliary symptoms, gallbladder motility, and cholecystectomy
    Antonio Colecchia
    Hepatology 45:259-60. 2007